She Y, Liu Z. Effect of Peptide Drug Liraglutide Nano-Formulation Combined with Sodium-Glucose Cotransporter-2 Inhibitor on Blood Lipids in Patients with Type 2 Diabetes: Peptide Drug Liraglutide Nano-Formulation and Type 2 Diabetes. Cell Mol Biol (Noisy-le-grand) [Internet]. 2022 Mar. 31 [cited 2024 Nov. 21];68(3):221-8. Available from: https://mail.cellmolbiol.org/index.php/CMB/article/view/4332